NIAID Goes Dark on Infectious Disease Trial Funding
Published Date: 4/3/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed video meeting on May 1, 2025, to review important grant applications for clinical trials. This meeting affects researchers seeking funding and keeps sensitive info private. It helps decide who gets money to fight infectious diseases and supports exciting new medical research.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed review decides clinical trial funding
If you are a researcher applying for the NIAID Clinical Trial Implementation Cooperative Agreement (U01, clinical trial required), a closed video meeting on May 1, 2025, from 11:00 a.m. to 1:00 p.m. will review and evaluate grant applications. That meeting helps decide who receives funding for infectious disease clinical trials.
Confidential handling of grant application details
The meeting will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. This keeps sensitive technical ideas and personal data private during the May 1, 2025 review.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in